Artron Laboratories Inc. was founded in 2002 by a team of dedicated research scientists. Today, Artron has established itself as a global leader in the progression of in-vitro diagnostic lateral flow tests that have revolutionized the market for disease diagnosis. At Artron, our mission is to overcome industry challenges and provide simple and affordable IVD products that meet your highest expectations. The combination of an experienced research team along highly developed production technology guarantees that our tests are of premium quality. Our extensive product catalog includes lateral flow tests for the detection of fertility hormones, infectious diseases, tumor markers, cardiac markers, drugs of abuse, food safety, and genetically modified organisms. Not only do we have a wide range of products, but we also have the necessary quality assurance and medical device licenses required for the worldwide distribution of our rapid test kits. Artron is an ISO 13485-certified company with products approved by the FDA, Health Canada, and CE. Our research and development facility located in Burnaby, British Columbia, is also compliant with Good Manufacturing Practices (GMP). Artron also offers customization services, which include but are not limited to the development of custom-made lateral flow tests, monoclonal antibodies, critical membrane components, as well as OEM services.